Cerrito F, Preziosi P
J Neurosci Res. 1985;14(4):423-31. doi: 10.1002/jnr.490140405.
In order to get better characterization of alpha 2-pre- and postsynaptic noradrenergic receptors in the rat brain, we investigated the alpha 2-receptor changes which take place during a 12-day treatment with the alpha 2-antagonists yohimbine (4 mg/kg) and mianserin (10 mg/kg). These treatments caused a significant increase in the sensitivity of hypothalamic synaptosomes to the inhibitory action of the noradrenergic agonist clonidine on the 3H-noradrenaline release elicited by K depolarization. Frontal cortex alpha 2-autoreceptors were not affected by drug treatments. However, the 3H-p-aminoclonidine (3H-PAC) binding to membranes from hypothalamus or frontal cortex from treated animals was the same as in controls. Changes in neural firing, elicited by the alpha 2-antagonists on noradrenergic neurons, could explain our results. The presynaptic autoreceptors may thus become hypersensitive to counteract the enhanced neurotransmitter release in the hypothalamus, where the noradrenaline is accumulated at the synaptic cleft. In the frontal cortex, where it seems that only 5% of the noradrenergic terminals make synaptic contacts with postsynaptic elements, the alpha 2-autoreceptors are less sensitive to an enhanced neurotransmitter release. Alternatively, they have scarce functional importance because the noradrenaline release is effectively modulated by the inhibitory recurrent locus coeruleus collaterals. At the postsynaptic level, the receptor down-regulation might be prevented by chronic presence of the antagonist drug. Thus the different behavior between pre- and postysynaptic alpha 2-receptors and between alpha 2-receptors of different brain areas may be ascribed to a different modulation rather than to different molecular arrangements.
为了更好地表征大鼠脑中α2 - 突触前和突触后去甲肾上腺素能受体,我们研究了用α2拮抗剂育亨宾(4毫克/千克)和米安色林(10毫克/千克)进行12天治疗期间发生的α2受体变化。这些治疗导致下丘脑突触体对去甲肾上腺素能激动剂可乐定抑制K去极化引发的3H - 去甲肾上腺素释放的敏感性显著增加。额叶皮质α2 - 自身受体不受药物治疗的影响。然而,用药物处理的动物下丘脑或额叶皮质膜上的3H - 对氨基可乐定(3H - PAC)结合与对照组相同。α2拮抗剂对去甲肾上腺素能神经元引发的神经放电变化可以解释我们的结果。因此,突触前自身受体可能变得超敏,以抵消下丘脑神经递质释放的增强,在下丘脑中去甲肾上腺素在突触间隙积累。在额叶皮质中,似乎只有5%的去甲肾上腺素能终末与突触后元件形成突触联系,α2 - 自身受体对增强的神经递质释放不太敏感。或者,它们的功能重要性稀缺,因为去甲肾上腺素释放受到抑制性蓝斑侧支循环的有效调节。在突触后水平,拮抗剂药物的长期存在可能会阻止受体下调。因此,突触前和突触后α2受体之间以及不同脑区的α2受体之间的不同行为可能归因于不同的调节,而不是不同的分子排列。